-+ 0.00%
-+ 0.00%
-+ 0.00%

BRIEF-US FDA Requires Safety Labeling Changes For Glp-1 RAs Due To Potential Increased Risk Of Rare But Serious Eye Condition

Reuters·11/09/2026 15:14:35

Please log in to view news